Page last updated: 2024-11-07

azauridine and Guillain-Barre Syndrome

azauridine has been researched along with Guillain-Barre Syndrome in 1 studies

Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Morales Vasquez, D1
Park, JG1
Ávila-Pérez, G1
Nogales, A1
de la Torre, JC1
Almazan, F1
Martinez-Sobrido, L1

Other Studies

1 other study available for azauridine and Guillain-Barre Syndrome

ArticleYear
Identification of Inhibitors of ZIKV Replication.
    Viruses, 2020, 09-18, Volume: 12, Issue:9

    Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Azauridine; Biphenyl Compounds; Carbamates; Cell S

2020